Aurora Cannabis to Strategically Enter the United States with Acquisition of Reliva, LLC A Market Leading Mass Retail CBD Platform

Go back to Aurora Cannabis to Strategically Enter the United States with Acquisition of Reliva, LLC A Market Leading Mass Retail CBD Platform

Aurora Cannabis (ACB:CN) (ACB) PT Raised to Cdn$27 at Cantor Fitzgerald; Positive on Reliva Deal

May 21, 2020 8:18 AM EDT

Cantor Fitzgerald analyst Pablo Zuanic raised the price target on Aurora Cannabis (ACB:CN) (NYSE: ACB) to Cdn$27.00 (from Cdn$22.00) while maintaining an Overweight rating after the company agreed to acquire Reliva.

The analyst commented, "ACB proved last Thursday (5/14) that it is making great strides with its reset (divestitures, cost cuts, cash flow improvement), and played down the risk of further dilution. Over the past 90 days into the print, the stock had been... More